Unaudited Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands		3 Months Ended
		Mar. 30, 2025	Mar. 31, 2024
Income Statement [Abstract]
Net revenue	[1]	$ 162,060	$ 164,586
Cost of revenue		105,734	116,349
Gross profit		56,326	48,237
Operating expenses:
Research and development		18,309	20,227
Sales and marketing		28,041	30,529
General and administrative		18,070	18,067
Litigation reserves, net		(37)	30
Restructuring and other charges		4,742	1,032
Total operating expenses		69,125	69,885
Loss from operations		(12,799)	(21,648)
Other income, net	[2]	8,171	2,850
Loss before income taxes		(4,628)	(18,798)
Provision for (benefit from) income taxes		1,406	(148)
Net loss		$ (6,034)	$ (18,650)
Net loss per share
Basic		$ (0.21)	$ (0.63)
Diluted		$ (0.21)	$ (0.63)
Weighted average shares used to compute net loss per share:
Basic		28,717	29,395
Diluted		28,717	29,395

[1] No individual foreign country represented more than 10% of the Company’s total net revenue in the periods presented.

[2] Amounts included interest income of $3.3 million and $2.5 million, and gain/(loss), net from derivatives not designated as hedging instruments of $(1.0) million and $1.5 million, for the three months ended March 30, 2025 and March 31, 2024, respectively. For the three months ended March 30, 2025, the amount also included proceeds of $4.7 million from a sale of patents.